Skip to content

Comparing effects of melatonin and duloxetine in the treatment of osteoarthritis

Comparing effects of melatonin and duloxetine in the treatment of osteoarthritis

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20200516047468N2
Enrollment
30
Registered
2024-04-15
Start date
2024-04-20
Completion date
Unknown
Last updated
2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteoarthritis disease. Osteoarthritis of knee

Interventions

Intervention 1: First intervention group: Duloxetine therapy is initiated at a dose of 60 mg and once daily and up to a maximum of 120 mg. Intervention 2: Second intervention group: this group treated

Sponsors

Shahid Beheshti University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to No maximum

Inclusion criteria

Inclusion criteria: Age over 40 years Knee osteoarthritis based on ACR creatria for at least 6 months Feeling pain or discomfort in the knee for at least 3 months on a daily basis or reducing significant limitations on the Joint involved for 1 month according to WOMAC No history of underlying diseases (including diabetes, inflammatory arthritis) OCP consumption, smoking

Exclusion criteria

Exclusion criteria: BMI>30 Recent history of knee surgery All cases of secondary osteoarthritis Drug and / or antidepressant use while studying Major psychiatric diseases

Design outcomes

Primary

MeasureTime frame
Knee pain rates based on WOMAC index. Timepoint: Measuring knee pain at the beginning of the study and three months later. Method of measurement: WOMAC index.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactParisa Delkash

Shahid Beheshti University of Medical Sciences

parisa.delkash@yahoo.com+98 21 7343 3000

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026